PMID- 28493393 OWN - NLM STAT- MEDLINE DCOM- 20191125 LR - 20191125 IS - 1463-1318 (Electronic) IS - 1462-8910 (Linking) VI - 20 IP - 3 DP - 2018 Mar TI - Final results of a European, multicentre, prospective, observational study of Permacol collagen paste injection for the treatment of anal fistula. PG - 243-251 LID - 10.1111/codi.13715 [doi] AB - AIM: Permacol collagen paste (Permacol paste) is an acellular cross-linked porcine dermal collagen matrix suspension for use in soft-tissue repair. The use of Permacol paste in the filling of anorectal fistula tract is a new sphincter-preserving method for fistula repair. The MASERATI100 study was a prospective, observational clinical study with the objective to assess the efficacy of Permacol collagen paste for anal fistula repair in 100 patients. METHOD: Patients (n = 100) with anal fistula were treated, at 10 European surgical sites, with a sphincter-preserving technique using Permacol paste. Fistula healing was assessed at 1, 3, 6 and 12 months post-treatment, with the primary end-point being healing at 6 months. Faecal continence and patient satisfaction were surveyed at each follow-up; adverse events (AEs) were monitored throughout the follow-up. RESULTS: At 6 months postsurgery, 56.7% of patients were healed and the percentage healed was largely maintained, with 53.5% healed at 12 months. Regarding AEs, 29.0% of patients had at least one AE, and 16.0% of patients had one or more procedure-related AE. Most AEs reported were minor and similar to those commonly observed after fistula treatment, and the incidence of serious adverse events was low (4.0% of patients). Regardless of treatment outcome, 73.0% of patients were satisfied or very satisfied with the procedure. CONCLUSION: Permacol paste is a promising sphincter-preserving treatment for anal fistulae and has minimal adverse side-effects. CI - Colorectal Disease (c) 2017 The Association of Coloproctology of Great Britain and Ireland. FAU - Giordano, P AU - Giordano P AD - Colorectal Department, Whipps Cross University Hospital, Barts Health, London, UK. FAU - Sileri, P AU - Sileri P AD - Surgery, University of Rome Tor Vergata, Rome, Italy. FAU - Buntzen, S AU - Buntzen S AD - Colorectal Surgery, Department of Surgery, Aarhus University Hospital, Aarhus, Denmark. FAU - Nunoo-Mensah, J AU - Nunoo-Mensah J AD - Department of Colorectal Surgery, King's College Hospital, London, UK. FAU - Lenisa, L AU - Lenisa L AD - General Surgery Unit, Casa di Cura Humanitas San Pio X, Milan, Italy. FAU - Singh, B AU - Singh B AD - Leicester General Hospital, Leicester, UK. FAU - Thorlacius-Ussing, O AU - Thorlacius-Ussing O AD - Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark. FAU - Griffiths, B AU - Griffiths B AD - NUTH Foundation Trust, Newcastle, UK. FAU - Vujovic, Z AU - Vujovic Z AD - Ninewells Hospital & Medical School, Dundee, Scotland, UK. FAU - Stuto, A AU - Stuto A AD - Coloproctology and Pelvic Floor Surgery, Policlinico Abano Terme, Padova, Italy. LA - eng PT - Journal Article PT - Multicenter Study PT - Observational Study PL - England TA - Colorectal Dis JT - Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland JID - 100883611 RN - 0 (Ointments) RN - 0 (Permacol) RN - 9007-34-5 (Collagen) SB - IM MH - Adult MH - Aged MH - Collagen/*administration & dosage MH - Drainage/*methods MH - Europe MH - Female MH - Humans MH - Injections MH - Male MH - Middle Aged MH - Ointments MH - Patient Satisfaction MH - Prospective Studies MH - Rectal Fistula/*therapy MH - Treatment Outcome OTO - NOTNLM OT - Anal fistula OT - Permacol collagen paste OT - faecal continence OT - sphincter-preserving technique EDAT- 2017/05/12 06:00 MHDA- 2019/11/26 06:00 CRDT- 2017/05/12 06:00 PHST- 2016/07/14 00:00 [received] PHST- 2016/12/07 00:00 [accepted] PHST- 2017/05/12 06:00 [pubmed] PHST- 2019/11/26 06:00 [medline] PHST- 2017/05/12 06:00 [entrez] AID - 10.1111/codi.13715 [doi] PST - ppublish SO - Colorectal Dis. 2018 Mar;20(3):243-251. doi: 10.1111/codi.13715.